GC Innovation America is a subsidiary of PTT Global Chemical Public Company Limited, the leading Thai chemicals company with global sales of more than US$ 15 billion. We are headquartered in Woburn, Massachusetts. Our mandate is to find and develop a wide range of new technology and materials, including biomaterials and biotechnology for global commercialization, either through own development, partnership collaboration or investment
Previously incorporated in 2009 as BioEnergy International LLC and subsequently renamed Myriant Corporation in 2011, we have developed organic acids that are used as chemical building blocks. We have successfully developed and demonstrated succinic acid production technology, with a demonstration plant located in Lake Providence, Louisiana. We also successfully developed several succinic acid derivative products that we current market to a variety of applications.
As part of the GC Group of companies, we now undertake a broader spectrum of activities to drive the innovation growth of GC. Today, we are proud to call ourselves GC Innovation America.
Anon’s career started at the Department of Mineral Resources, Thailand and covers more than 30 years in government service and various roles of responsibility with PTT Group including pipeline construction, gas compression, system analysis, natural gas marketing and transmission, natural gas supply and trading, corporate strategy and business development, Exploration & Production Business and Petrochemical Business.
He is currently the Chairman, PTT Chemical International (Asia Pacific ROH) Limited and a member of the Board of Directors PTT Global Chemical Public Company Limited.
Anon holds a Bachelor’s degree in Geology from Chulalongkorn University, an MBA from Thammasart University, an Honorary Degree of Doctor of Public Administration from Bangkokthonburi University and certificates in “Project Investment Appraisal and Management" and “Global Leadership" from Harvard University.
Dr. Kongkrapan has more than 20 years of experience in the global petrochemical and chemical arenas. His areas of expertise include overseeing corporate strategy, business development, major project development, international M&A, R&D, and corporate finance & investor relations divisions.He is currently the Chief Operating Officer of Upstream Petrochemical Business at PTT Global Chemical Public Company Limited (GC) and a member of the Board of Directors in several companies under GC’s umbrella, such as Thai Tank Terminal Limited in Thailand, PTT Chemical International Pte. Ltd. in Singapore, Emery Oleochemicals Group in Malaysia, Vencorex Holding in France, NatureWorks LLC, GC Ventures Corporation, PTTGC America, and PTTGC USA in USA.
Moreover, Dr. Kongkrapan has been working with GC throughout his career, holding various senior positions including Executive Vice President of International Business Operations, Senior Vice President overseeing Performance Products Business Unit and Corporate Business Development, CEO of Emery Oleochemicals Group, Chairman of the board for a number of GC’s subsidiaries (TOC Glycol and Thai Ethanolamines), and President and Board Member of Thai Oleochemicals.
He has a Bachelor of Engineering in Chemical Engineering from Chulalongkorn University and Ph.D. in Chemical Engineering from the Houston University, Texas.
Dr.Chaya Chandavasu is currently Senior Vice President of Science & Innovation at PTT Global Chemical Public Company Limited (GC), one of the leading and largest chemical companies in Asia, and a member of the Board of Directors in several companies under GC’s umbrella, such as Solution Creation Company Limited in Thailand, GC Ventures Company Limited, GC Ventures America Corporation. He is responsible for company’s innovation strategy, new project development and scouting / assessing new emerging technologies to create long-term competitive advantages as well as overseeing GC’s Science & Innovation Center. With more than 20 year of experience in the global oil & gas, petrochemical and chemical industry, his experience includes technology & engineering, marketing & sales and research & development.
Dr. Chaya has a Bachelor of Chemistry (First Class Honors) from Mahidol University, Thailand and Master and Ph.D. of Chemical Engineering from New Jersey Institute of Technology, USA.
Pari joined GC Innovation America (GCIA) in 2015 from PTT Global Chemical Plc. where she serves as Vice President. She has more than 10 years of experience across various countries within the PTT Group of companies in various management and executive roles in corporate planning and strategy, financial planning, mergers & acquisitions, corporate restructuring, and international business performance management.
Prior to joining the PTT Group, Pari was a Principal with a boutique investment banking firm specializing in mergers, acquisitions and divestment, and has led the execution of several strategic transactions for clients including the PTT Group in the coal mining, gas retail services, power utilities and petrochemical sectors throughout her years in investment banking career.
Pari earned an MBA from the Fuqua School of Business, Duke University.
David’s career spans to more than 30 years of domestic and international experience in sales, market development, profitability and key account management in bio-chemicals, specialty chemicals, commodity chemicals and materials industries. He joined GCIA in 2010 and has worked in sales, marketing and business development roles.
Most recently, David was the President of TFL USA Canada Inc., a multi-million dollar specialty chemicals company for the leather industry, where he led sales, technical and administrative teams and served as Global Account Manager for multiple accounts. Previously, David was President of Inchem Corporation, a privately held coatings resins and custom manufacturer.
For more than twenty years, David held many successful executive sales and marketing positions for Hoechst Celanese Corporation, a global chemical enterprise including launching of a subsidiary, Vianova Resins USA, where he served as General Manager.
David holds a B.S. in Chemical Engineering, from the University of Massachusetts (formerly Lowell David holds a B.S. in Chemical Engineering, from the University of Massachusetts (formerly Lowell
Tina joined GCIA in 2009 and currently leads the technology scouting, CVC deal sourcing and new business development, and open innovation efforts for GC Group in North America. She has previously served in various roles at GCIA, including technology transfer & scale-up, application development, and business development.
Prior to joining GCIA, Tina was at Eastman Chemical’s Corporate Research Division in a Strategic Process Innovation and Evaluation group specializing in evaluating and developing new technologies.Tina has a Ph.D. in Chemical Engineering and a Certificate in Management of Technology from Georgia Institute of Technology.
Rog joined GCIA in 2008 and currently heads up the Molecular Biology department, specializing in genetic engineering of bacteria and yeasts for production of chemicals by fermentation. Rog has 34 years of experience in biochemistry and molecular biology for a wide variety of commercial applications including foods and beverages, antibiotic discovery, DNA diagnostics, human and animal nutrition, and commodity chemicals. Prior to joining GCIA, Rog was a Senior Director of Molecular Biology at OmniGene Bioproducts, Inc., where he engineered microbes to produce the vitamins biotin and pantothenic acid, and the amino acid L-methionine.
Rog has a B.S in Zoology and Mathematics from the University of Michigan (Summa Cum Laude) and a Ph.D. in Biology from Harvard University. Rog won a Helen Hay Whitney Postdoctoral Fellowhip, which was carried out also at Harvard.
Theron came to GCIA in 2008 from OmniGene BioProducts where he had developed fermentation processes for the commercial production of vitamins and enzymes for BASF and DSM. Previously he was with Hoffmann-LaRoche where he directed a pilot plant, analytical support and served as consultant for strain improvement and large scale antibiotic production. At GCIA, his group did the scale-up, commissioning and training for succinic acid fermentation at our Lake Providence, LA demonstration plant. Under his supervision, his group has also optimized microorganisms for the utilization of corn, sugar cane, cellulose, glycerol and sorghum feedstocks to succinic acid, lactic and muconic acid. The analytical group is responsible for product release QC and well as support for our product applications development.
Theron earned his M.S. in Microbiology from the University of Wisconsin and received his Ph.D. from the Waksman Institute of Microbiology at Rutgers.
Eric has served as our Corporate Controller since July 2011, and previously held the position of Director of Financial Reporting at GCIA since July 2008. Eric has over 30 years of experience in corporate accounting and financial management including serving in management roles in two NYSE listed companies.
Eric is a Certified Public Accountant with a Bachelor of Science degree in accounting from the University of New Hampshire.
Doreen has over 25 years designing and leading human resource and immigration programs for both start-up and mature organizations. Mindful of aligning the needs of both the organization and employees, she serves as an insightful change agent and transformational leader who embodies a passion to be of service to others.
Doreen served as the Director of Human Resources for 17 years at the Immune Disease Institute (IDI). After leading the transition of IDI’s human resources department into Boston Children’s Hospital, Doreen joined GCIA in 2014. She has since provided strategic operational support for GCIA’s corporate office, research & development department and start-up of our demonstration facility in Lake Providence, LA. She continues to lead GCIA through strategic human resource planning to develop and drive organizational effectiveness and support the company on all major initiatives as it looks toward the future.
Doreen holds a B.S. in Speech Communication, from Northeastern University located in Boston, Massachusetts
Michael joined the GCIA team in 2011 to serve as the Construction Manager in order to oversee the General Contractor during the construction of the Myriant Lake Providence Inc. demonstration plant for succinic acid producing technology in Lake Providence, LA. He currently holds the position of Plant Manager.
Michael has over 35 years’ experience in EPC (Engineering Procurement & Construction) from companies such as KBR (Kellogg Brown & Root), CB&I (Chicago Bridge & Iron) and S&B Engineering and Constructors building plants throughout the U.S. ranging from Chemical, Refinery and Power Plants. Further to that, he has held positions ranging from Construction Manager, Superintendent and Turnover Coordinator. Michael’s last 15 years have been spent constructing, commissioning and starting up plants along with training client operations personnel, the safest and most cost effective approaches in plant operations.
Michael holds a B.S in Mechanical Engineering from New Mexico State University in Las Cruces, New Mexico. He also holds a Core Curricula PE and Pipefitter PE through NCCER (National Center for Construction Education and Research).